Manufacturers make claims about their products' efficacy in killing disease-causing pathogens, but what do infection preventionists really know about the validity of these claims? In a series of articles, we'll take a look at what practitioners in infection prevention should understand about the science behind label claims and marketing hype, including the FDA clearance and EPA registration processes, as well as testing protocols that preceded a product's appearance in the marketplace. In this first article, we talk to Wallace Puckett, PhD, vice president of science and technology for STERIS Corporation, about the knowledge gaps that currently exist relating to research and development of disinfectants, antibacterials, antimicrobials, microbicides and sporicides.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.